Isolated Abdominal Wall Metastasis From Ovarian Cancer

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 17

ISOLATED ABDOMINAL WALL METASTASIS

FROM OVARIAN CANCER


By Dr RADHIKA GOPAKUMAR
Moderator : Dr Shripad Hebbar
Chief complaints

 Mrs X, a 52 year old female patient


 Hailing from Udupi
 Middle socio economic status
 S/P Total abdominal hysterectomy with bilateral salpingo oophorectomy(TAH and BSO)
and partial omentectomy, came with bilateral lower limb weakness and pain radiating to
both flanks and back, abdominal discomfort since 15 days
History of presenting illness
 On routine health checkup at a local hospital, USG abdomen (July 23 rd 2020) showed
Uterus 8 x 4.6 x 3.5 cm, small posterior wall fibroid 8 x 9 mm , right ovarian cyst 73 x 78
x 55 mm with turbid fluid with internal septations and an echogenic lesion (?calcific) in
cyst wall. Left ovary – normal .
 She was advised ovarian cystectomy initially, but lost to follow-up.
 She developed amenorrhea of 6 months duration (April to September 2022) followed by
bleed P/V of 20 days duration in October 2022.
 USG abdomen and pelvis (September 19th 2022) showed Uterus anteverted 8 x 4 x 3.2
cm , ET – 7 mm, a large right abdominopelvic adnexal cyst of 15.6 x 13 x 9.6 cm in size
with multiple septations and internal echoes displacing bowel loops laterally , bilateral
ovaries – not visualized and umbilical hernia of 1.2 cm with omental fat as content.
History of presenting illness
 CECT (A and P)(October 6th 2022) showed a right
abdominopelvic adnexal lesion of 11 x 13.6 x 16 cm)
 MRI (A and P)(October 8th 2022) showed a right ovarian
complex multiloculated cyst 17 x 14 cm adhered to peritoneum
and bowel loops, attached to right cornual end of uterine
fundus)
 She underwent TAH with BSO and partial omentectomy on
October 2022 at KIMS, Hubli. Post operative period was
uneventful. Ascitic fluid sent for analysis showed features
suspicious of malignancy.

MRI abdomen and pelvis


History of presenting illness
 Specimen sent for HPE was reported as atrophic
endometrium and benign mucinous cystadenoma of right
ovary .
 She was asymptomatic since discharge (October 2022) for
8 months. Presently she developed bilateral lower limb
weakness and pain radiating to both flanks and back,lower
abdominal discomfort since 15 days.
 She had consulted a gynecologist at outside hospital 2
weeks back.
 Ultrasound abdomen with pelvis(A and P) showed (5 th
July 2023) irregular hypoechoic area 7 x 5.5 cm within
deep layers of abdominal wall in midline of hypogastrium
at site of previous surgery.
? Inflammatory mass ?neoplasm- involving soft tissue planes
including muscular planes extending upto pubic and inguinal
areas, uterus and adnexa were not visualized. USG abdomen and pelvis
History of presenting illness
 MRI (A and P) showed an ill defined infiltrative
enhancing lesion 7 x 9.1 x 7.5 cm involving lower
abdominal wall (rectus abdominus muscle extending
into subcutaneous space along surgical scar)
Posteriorly extending upto the pre-vesical space with loss of
fat planes with anterior wall of bladder. Laterally upto
inguinal region and along pelvic walls, predominantly on
left side - aggressive fibromatosis , endometriosis were
suspected

MRI abdomen and pelvis


History of presenting illness
 On neurology and orthopaedics evaluation at Tejasvini hospital, Mangalore – MRI lumbar
spine showed (18/07/2023) altered signal intensity lesions in L3, L4, L5 vertebral bodies ,
sacrum, left iliac bone and right femur. Multiple enlarged abdominal retroperitoneal
pre/para aortic nodes were noted likely metastasis with D/D being lymphoma, large lesion
was partially visualized in prevesical space involving muscular and subcutaneous space of
anterior abdominal wall.
 She was given symptomatic treatment. She came to Kasturba Hospital for second opinion
on 23rd July 2023.
 No white discharge or bleeding P/V, burning micturition, stress urinary incontinence or
dysuria.
 No history of nausea, dyspepsia, post meal distension, loss of appetite, weight loss or
constipation.
Past History
 Menstrual History: Post TAH with BSO and partial omentectomy
 Obstetric History: P2L2Ab1, previous 2 LSCS, LCB – 17 years, sterilized
 Family History : Nil gynecological malignancy in family.
 Surgical History: s/p TAH and BSO with partial omentectomy (October 2022) Sterilised 17
years back.
 Medical History: Nil comorbidities
Examination
 General condition – fair
Moderately built and nourished
Height: 160 cm, Weight : 51 kg, BMI – 19.9 kg/m2
Afebrile, PR: 70 bpm, BP: 110/70 mm Hg,
No pallor, icterus, cyanosis, lymphadenopathy or pedal edema
 Breast and Thyroid – clinically normal
 CVS: S1 S2+
 RS: NVBS

 Per abdomen:
Inspection –
Abdomen appears distended
No scars or sinuses
Midline vertical scar wound healthy
Palpation : Large diffuse swelling in suprapubic and pubic region
 P/S and P/V- Vault healthy
Evaluation
 Lab investigations:
HbA1c – 5.3%, RBS – 123 mg/dl
Hemoglobin – 11 g/dl, Platelet count – 203 x 1000/microlilter
Total count – 13.9 x 10000/microliter
TSH – 2.3 microIU/mL
URE- WBC -11.5/hpf, RBC- 78.5/hpf, yeast- 22.3/ hpf
HbsAg and HIV – NR
PT- 11 sec, INR – 0.97 , APTT – 27.8 sec
Urea/creatinine/uric acid – 14/0.48/3 mg/dl
Sodium/potassium/chloride – 130.1/4.2/93.2 mmol/L
Total /Direct Bilirubin – 0.79/0.31 mg/dl
AST/ALT/ALP – 44.6 /126/33.1
CEA - 33.1 ng/dl , CA 19.9 - < 02 U/mL , CA 125 – 1200 U/mL
Evaluation

 TVS done showed a well defined mass 5.5 x 2 x 4 cm arising from anterior abdominal
wall, uterus and ovaries not visualized.
 Interventional radiology consultation was sought and ultrasound guided trucut biopsy from
abdominal mass taken – she was discharged and advised for review with report. Recently,
biopsy has been reported with features of metastatic adenocarcinoma with immune profile
suggestive of mullerian primary (CK7 and PAX8 positive).
 Medical oncology consultation was sought in view of abdominal mass – review is
ongoing .
Treatment plan
Based on trucut biopsy report of abdominal mass, medical oncology review ,
further evaluation (to look for any further sites of metastasis) and treatment
plan would be decided.

Diagnosis

P2L2Ab1 with previous 2 LSCS S/P TAH with BSO and partial omentectomy with abdominal
wall metastasis from ovarian cancer
Things to ponder

 Based on the HPE report of specimen sent post TAH with BSO and partial omentectomy in
October 2022 – was the right ovarian cyst really benign mucinous cystadenoma ?
 Is the abdominal wall mass presently fibromatosis or metastasis from ovarian neoplasm ?
Similar studies

 In a case report (2019), a 50 year old female


had underwent TAH 10 years ago for uterine
fibroid (2009)
 She presented at Maternity and child welfare
hospital, Delhi (2019) with ulcerated
swelling over left lower abdominal wall post
optimal cytoreduction (BSO , total
omentectomy, pelvic and para-aortic lymph
node dissection done 18 months ago).
 Wide local excision of abdominal wall mass
- histopathology confirmed metastatic
endometroid cancer of ovary. All margins
were negative. She received 6 cycles of
Choudhary D, Sharma G, Singh T, Chishi N, Garg PK. Isolated abdominal wall metastasis in early ovarian cancer: a chemotherapy.
true systemic metastasis or local tumour cells implantation. J Obstet Gynaecol. 2019 Jul;39(5):724-726. doi:
10.1080/01443615.2019.1578734. Epub 2019 Apr 22. PMID: 31010379.
Similar case reports
 Three cases of abdominal wall metastases from ovarian cancer after laparoscopy were reported.
 One patient had an implant of serous papillary carcinoma of low malignant potential at the trocar
site after laparoscopic left salpingooophorectomy and right ovarian biopsy. She was treated with
cyclophosphamide and cisplatin.
 Other 2 patients were referred following laparoscopy wherein Ascites drained and samples taken
from pelvic carcinomatosis(Poorly differentiated and serous papillary carcinoma seen in HPE).
They presented with palpable subcutaneous masses upto 8 cm at trocar site. Staging laparotomy
and optimal debulking followed by carboplatin and cyclophosphamide commenced
 Laparoscopic surgery is inappropriate in patients with malignant ascites or when preoperative
findings are suggestive of ovarian cancer.

Gleeson NC, Nicosia SV, Mark JE, Hoffman MS, Cavanagh D. Abdominal wall
metastases from ovarian cancer after laparoscopy. Am J Obstet Gynecol. 1993
Sep;169(3):522-3. doi: 10.1016/0002-9378(93)90611-l. PMID: 8018126.
Similar case reports
.
 Ataseven et al have studied the impact of Abdominal wall metastasis (AWM) from ovarian cancer
on prognosis and survival (Ataseven et al. 2016).
 They reported FIGO stage IV cancers with only AWM had better overall survival then FIGO stage
IV cancers with other distal metastasis.
 Overall survival in stage IV B AWM was similar to stage IIIC. So according to Atasevan , AWM
should be classified as stage IIIC than stage IVB.

Ataseven B, du Bois A, Harter P, Prader S, Grimm C, Kurzeder C, Schneider S, Heikaus S, Kahl A, Traut A,
Heitz F. Impact of Abdominal Wall Metastases on Prognosis in Epithelial Ovarian Cancer. Int J Gynecol Cancer.
2016 Nov;26(9):1594-1600. doi: 10.1097/IGC.0000000000000826. PMID: 27654263.
Thank you

You might also like